565 related articles for article (PubMed ID: 20212113)
1. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
[TBL] [Abstract][Full Text] [Related]
2. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase.
Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC
Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157
[TBL] [Abstract][Full Text] [Related]
3. BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity.
Chiu YH; Lee JY; Cantley LC
Mol Cell; 2014 Apr; 54(1):193-202. PubMed ID: 24657164
[TBL] [Abstract][Full Text] [Related]
4. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement.
Brachmann SM; Yballe CM; Innocenti M; Deane JA; Fruman DA; Thomas SM; Cantley LC
Mol Cell Biol; 2005 Apr; 25(7):2593-606. PubMed ID: 15767666
[TBL] [Abstract][Full Text] [Related]
5. Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase.
Luo J; Sobkiw CL; Logsdon NM; Watt JM; Signoretti S; O'Connell F; Shin E; Shim Y; Pao L; Neel BG; Depinho RA; Loda M; Cantley LC
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10238-43. PubMed ID: 16006513
[TBL] [Abstract][Full Text] [Related]
6. Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.
Geering B; Cutillas PR; Nock G; Gharbi SI; Vanhaesebroeck B
Proc Natl Acad Sci U S A; 2007 May; 104(19):7809-14. PubMed ID: 17470792
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.
Taniguchi CM; Tran TT; Kondo T; Luo J; Ueki K; Cantley LC; Kahn CR
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12093-7. PubMed ID: 16880400
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of phosphoinositide 3-kinase.
Rajala RV; McClellan ME; Chan MD; Tsiokas L; Anderson RE
Biochemistry; 2004 May; 43(19):5637-50. PubMed ID: 15134438
[TBL] [Abstract][Full Text] [Related]
9. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex.
Luo J; Field SJ; Lee JY; Engelman JA; Cantley LC
J Cell Biol; 2005 Aug; 170(3):455-64. PubMed ID: 16043515
[TBL] [Abstract][Full Text] [Related]
10. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit.
Ueki K; Algenstaedt P; Mauvais-Jarvis F; Kahn CR
Mol Cell Biol; 2000 Nov; 20(21):8035-46. PubMed ID: 11027274
[TBL] [Abstract][Full Text] [Related]
11. p85 Associates with unphosphorylated PTEN and the PTEN-associated complex.
Rabinovsky R; Pochanard P; McNear C; Brachmann SM; Duke-Cohan JS; Garraway LA; Sellers WR
Mol Cell Biol; 2009 Oct; 29(19):5377-88. PubMed ID: 19635806
[TBL] [Abstract][Full Text] [Related]
12. Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?
Geering B; Cutillas PR; Vanhaesebroeck B
Biochem Soc Trans; 2007 Apr; 35(Pt 2):199-203. PubMed ID: 17371237
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor β (TGF-β) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation.
Cattley RT; Lee M; Boggess WC; Hawse WF
J Biol Chem; 2020 Jun; 295(24):8236-8251. PubMed ID: 32358062
[TBL] [Abstract][Full Text] [Related]
14. Impact of p85α Alterations in Cancer.
Marshall JDS; Whitecross DE; Mellor P; Anderson DH
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30650664
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the PI3K pathway through a p85α monomer-homodimer equilibrium.
Cheung LW; Walkiewicz KW; Besong TM; Guo H; Hawke DH; Arold ST; Mills GB
Elife; 2015 Jul; 4():e06866. PubMed ID: 26222500
[TBL] [Abstract][Full Text] [Related]
16. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
[TBL] [Abstract][Full Text] [Related]
17. N-terminal domains of the class ia phosphoinositide 3-kinase regulatory subunit play a role in cytoskeletal but not mitogenic signaling.
Hill KM; Huang Y; Yip SC; Yu J; Segall JE; Backer JM
J Biol Chem; 2001 May; 276(19):16374-8. PubMed ID: 11278326
[TBL] [Abstract][Full Text] [Related]
18. TAT-protein blockade during ischemia/reperfusion reveals critical role for p85 PI3K-PTEN interaction in cardiomyocyte injury.
Zhu X; Shao ZH; Li C; Li J; Zhong Q; Learoyd J; Meliton A; Meliton L; Leff AR; Vanden Hoek TL
PLoS One; 2014; 9(4):e95622. PubMed ID: 24752319
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.
Jiang BH; Jiang G; Zheng JZ; Lu Z; Hunter T; Vogt PK
Cell Growth Differ; 2001 Jul; 12(7):363-9. PubMed ID: 11457733
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation.
Mellor P; Marshall JDS; Ruan X; Whitecross DE; Ross RL; Knowles MA; Moore SA; Anderson DH
Sci Rep; 2018 May; 8(1):7108. PubMed ID: 29740032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]